The FLUNITY-HD study, pooled analysis including 466,320 randomized older adults, demonstrated that high-dose inactivated influenza vaccine (HD-IIV) provided proven superior protection against hospitalization outcomes than standard-dose inactivated influenza vaccine (SD-IIV) among adults aged ≥65 years. Whether th...
K. Hosseini, N. Johansen, D. Modin et al.· European Heart Journal· 0 citations
A prespecified analysis of the complete two-season DAN-RSV trial cohort will examine the vaccine effectiveness (VE) of RSVpreF versus no vaccine on respiratory and CV events among participants with or without pre-existing ASCVD.
M. Pareek, M. Lassen, M. Yafasov et al.· European Heart Journal· 0 citations
In patients with non-dialysis dependent CKD and unexplained dyspnea, a higher H2FPEF score was independently associated with an increased risk of all-cause mortality and incident HF.
A. Al-Rubai, J. Christensen, F. S. Davidovski et al.· European Heart Journal· 0 citations
Higher AHI values preceded HF hospitalizations and were independently associated with increased risk of HF hospitalization, highlighting the potential clinical value of device-based sleep apnea monitoring, warranting further validation.
T. Bekfani, J. Christensen, J. Simonsen et al.· European Heart Journal· 0 citations
AIM
This trial investigated whether colchicine, an anti-inflammatory treatment, affects cardiovascular structure and function, assessed by arterial stiffness, blood pressure and biochemistry, compared with placebo.
METHODS
COHERENT was a randomized, double-blind, placebo-controlled trial of the effects of colchicine...
A. Langhoff, N. Johansen, K. Bartholdy et al.· European Journal of Preventi...· 0 citations
BACKGROUND
Influenza vaccination is recommended for cardiovascular secondary prevention, but the comparative effectiveness of different dose strategies remains incompletely characterised.
METHODS
We searched MEDLINE, Embase, and CENTRAL for randomised trials comparing high-dose (HD-IIV), double standard-dose, standar...
Joshua J. Hon, T. Aikawa, T. Biering-Sørensen et al.· American Heart Journal· 0 citations
AIMS
To investigate the association between serial high-sensitivity cardiac troponin-T (hs-TnT) concentrations and subsequent heart failure in individuals presenting with suspected acute coronary syndrome (ACS).
METHODS AND RESULTS
Utilizing Danish nationwide registries, we identified individuals without known heart...
Philip Ahle Erichsen, Majid Afzal, Christina Byrne et al.· International Journal of Car...· 1 citation
BACKGROUND
Respiratory syncytial virus (RSV) is an important cause of severe respiratory disease in adults, with the highest burden among older adults and individuals with chronic health conditions. The bivalent RSV prefusion F (RSVpreF) vaccine has been shown to prevent RSV-associated respiratory illness, but data fro...
M. Lassen, S. Christensen, M. Yafasov et al.· NEJM Evidence· 1 citation
BACKGROUND
Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty...
C. Espersen, N. Johansen, D. Modin et al.· The Lancet Healthy Longevity· 0 citations
Abstract Introduction Sex differences in chronic heart failure are well established, but corresponding differences in acute heart failure (AHF), particularly in multimodal imaging findings and short-term recovery, remain incompletely characterized. Methods In this prospective observational study, 567 adults hospitalize...
A. Khoraizat, F. Davidovski, C. Espersen et al.· ESC Heart Failure· 0 citations
In adults aged 60 years or older, RSVpreF vaccination reduced hospitalisations for RSV-related respiratory tract disease with no statistical evidence of effect modification by immunosuppression status; however, the study was not powered to exclude subgroup differences.
A. Reimer Jensen, M. H. Højbjerg Lassen, N. Johansen et al.· The Lancet Healthy Longevity· 0 citations
Acute heart failure (AHF) is a major global health challenge, yet the relationship between New York Heart Association (NYHA) classification and objective markers such as echocardiography, lung ultrasound (LUS), and biomarkers remains unclear.
A. Al-Rubai, F. Davidovski, C. Espersen et al.· Echocardiography· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.